Psoriasis is a common, chronic immune-mediated skin disorder. Recent advances in the understanding of the immunopathogenesis of psoriasis have led to the development of biological agents designed to target the molecular mechanisms of the condition. These provide new and effective treatments for patients with moderate to severe psoriasis.
Wolfram Sterry, Juliet N. Barker, Wolf‐Henning Boehncke, J.D. Bos, Sergio Chimenti, Enno Christophers, M. de la Brassinne, Christopher Em Griffiths, Andreas Katsambas, Knud Kragballe, Charles Lynde, Alan Menter, J.‐P. Ortonne, Kim Papp, Jörg C. Prinz, Berthold Rzany, J.R. Rönnevig, J.‐H. Saurat, Mona Ståhle, Fernando Stengel, P.C.M. van de Kerkhof, John J. Voorhees
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.